Cargando…
The use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model
Cryotherapy has emerged as a primary treatment option for prostate cancer(CaP); however, incomplete ablation in the periphery of the cryogenic lesion can lead to recurrence. Accordingly, we investigated the use of a nontoxic adjunctive agent, Vitamin D(3), with cryotherapy to sensitize CaP to low te...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094482/ https://www.ncbi.nlm.nih.gov/pubmed/21221127 http://dx.doi.org/10.1038/pcan.2010.52 |